The path linking excessive daytime sleepiness and activity of daily living in Parkinson's disease: the longitudinal mediation effect of autonomic dysfunction
- PMID: 35487997
- DOI: 10.1007/s10072-022-06081-0
The path linking excessive daytime sleepiness and activity of daily living in Parkinson's disease: the longitudinal mediation effect of autonomic dysfunction
Abstract
Background: Excessive daytime sleepiness (EDS) and autonomic dysfunction have been verified to impair activity of daily living (ADL) in patients with Parkinson's disease (PD). Whether EDS can affect ADL in PD patients through autonomic dysfunction is still unclear. The purpose of this study is to explore the longitudinal mediation effect of autonomic dysfunction between EDS and ADL.
Methods: Data used in this study were from six-follow-up visits of 413 patients with newly diagnosed PD from the Parkinson's Progression Markers Initiative (PPMI). We used latent growth mediation modeling (LGMM) to explore whether the autonomic dysfunction is a longitudinal mediator between EDS and ADL.
Results: The results showed that as the disease progresses, EDS (P < 0.001) and autonomic dysfunction (P < 0.001) gradually worsened and ADL (P < 0.001) gradually decreased in PD patients. In addition, the more severe the patients' EDS symptom, the more worsened the symptoms of autonomic dysfunction, which result in a decrease in ADL. Both the intercept (95% CI: 0.142, 0.308) and the slope (95% CI: 0.083, 0.331) of autonomic dysfunction showed a partial mediating effect, and a longitudinal mediation effect was presented.
Conclusion: Longitudinal changes in EDS affect the ADL of PD patients directly or indirectly by affecting the symptoms of autonomic dysfunction. Controlling the symptoms of autonomic dysfunction may improve the ADL of PD patients with EDS.
Keywords: Activity of daily living; Autonomic dysfunction; Excessive daytime sleepiness; Mediation analysis; Parkinson’s disease.
© 2022. Fondazione Società Italiana di Neurologia.
References
-
- Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397(10291):2284–2303. https://doi.org/10.1016/S0140-6736(21)00218-X - DOI - PubMed
-
- Rajiah K, Maharajan MK, Yeen SJ, Lew S (2017) Quality of life and caregivers’ burden of Parkinson’s disease. Neuroepidemiology 48(3–4):131–137. https://doi.org/10.1159/000479031 - DOI - PubMed
-
- Hussein A, Guevara CA, Del Valle P, et al (2021) Non-motor symptoms of Parkinson’s disease: the neurobiology of early psychiatric and cognitive dysfunction. Neuroscientist, 10738584211011979 https://doi.org/10.1177/10738584211011979
-
- Santos García D, de Deus Fonticoba T, Suárez Castro E et al (2019) Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson’s disease patients: results from the COPPADIS study cohort. Parkinsonism Relat Disord 66:151–157. https://doi.org/10.1016/j.parkreldis.2019.07.031 - DOI - PubMed
-
- Santos-García D, de la Fuente-Fernández R (2013) Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease. J Neurol Sci 332(1–2):136–140. https://doi.org/10.1016/j.jns.2013.07.005 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
